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W?iO OWNS BIOTECHNOLOGY4 
Canberra -- Who owns biotechnology breakthroughs? How can poor countries 
profit from high-tech developments, particularly in food production? Where 
can genetically'engineered plants or animals be released? 
0 These and other issues will be explored at an international seminar to be held May 25-27, at the Becor Building, Gordon Street, Canberra Civic. The seminar, 
"Agricultural Biotechnology Opportunities for International Development," is 
being held in conjunction with a meeting of the Consultative Group on 
International Agricultural Research (CGIAR), which supports a variety of major 
food crop research programs in developing countries. 
"Biotechnology is extremely relevant to Australia's international aid 
efforts," according to Gabrielle Persley, Research Program Coordinator of the 
Australian Centre for International Agricultural Research (ACIAR). "We have a 
good deal of biotech expertise in this country, and are interested in its 
e commercial development." 
Advanced biotechnology-- involving techniques such as tissue culture, gene 
transfer, and protoplast fusion-- may hold the key to some of the more 
difficult agricultural problems in developing nations that are currently 
undergoing food shortfalls. 
Biotechnology may, for example, be used to increase a plant's ability to 
biologically "fix" nitrogen from the air as a natural fertilizer, or to modify 
the character of some vegetable oils to make them more marketable in developed 
countries. 
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However, such research is expensive. Concern that developing countries may 
become totally dependent on industrialized nations for the benefits of 
advanced techniques has prompted an extensive study by the Australian 
government and two international organizations--the World Bank and the 
International Service for National Agricultural Research (ISNAR), in The 
Netherlands, who are sponsoring the Canberra seminar. Persley is on assignment 
in the Netherlands from ACIAR to coordinate the study, which will be released 
in final form in late 1989. 
Delegates are expected from ASEAN member countries and several African and 
Latin American nations, as well as representatives of the international 
research centers and donor organizations attending the CGIAR meeting. 
"The protection of intellectual property rights is probably the most 
controversial issue before the seminar," Persley says. "Many developing 
countries have no provision for patents or copyrights. As private sector 
investment in biotechnology increases, ways must be found to negotiate for 
their results for use in these countries." 
According to Persley, controversy will also center on the release of 
0 
genetically engineered materials, and how less developed countries can ensure 
the safety of these practices within their borders. 
e "We expect to see recommendations coming out of the seminar for national 
biosafety review bodies," Persley says. "The thirteen international 
agricultural research centers supported by the CGIAR may be asked to provide 
developing country governments with annually updated information on the 
experiences and current policies of countries that have biotechnology safety 
review mechanisms." 
Seminar participants will also review the structure of the biotechnology 
industry in industrialized countries, and opportunities for public and private 
sector collaboration. The results of studies on the likelihood of modern 
biotechnology contributing to the production of vegetable oil crops, wheat, 
bananas, cocoa and coffee will also be presented. 
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